Cargando…
SLC13A5 Deficiency Disorder: From Genetics to Gene Therapy
Epileptic encephalopathies may arise from single gene variants. In recent years, next-generation sequencing technologies have enabled an explosion of gene identification in monogenic epilepsies. One such example is the epileptic encephalopathy SLC13A5 deficiency disorder, which is caused by loss of...
Autores principales: | Goodspeed, Kimberly, Liu, Judy S., Nye, Kimberly L., Prasad, Suyash, Sadhu, Chanchal, Tavakkoli, Fatemeh, Bilder, Deborah A., Minassian, Berge A., Bailey, Rachel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498415/ https://www.ncbi.nlm.nih.gov/pubmed/36140822 http://dx.doi.org/10.3390/genes13091655 |
Ejemplares similares
-
Gene Therapy: Novel Approaches to Targeting Monogenic Epilepsies
por: Goodspeed, Kimberly, et al.
Publicado: (2022) -
Immune Responses and Immunosuppressive Strategies for Adeno-Associated Virus-Based Gene Therapy for Treatment of Central Nervous System Disorders: Current Knowledge and Approaches
por: Prasad, Suyash, et al.
Publicado: (2022) -
Growth and Overall Health of Patients with SLC13A5 Citrate Transporter Disorder
por: Brown, Tanya L., et al.
Publicado: (2021) -
Epilepsy and EEG Phenotype of SLC13A5 Citrate Transporter
Disorder
por: Yang, Qian-Zhou, et al.
Publicado: (2020) -
Optical coherence tomography features in brothers with aspartylglucosaminuria
por: Goodspeed, Kimberly, et al.
Publicado: (2018)